Document Detail

Intermediate endpoints for atherosclerosis in hypertension.
MedLine Citation:
PMID:  9495636     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Event-based trials of antihypertensive therapy, although they have been essential in showing the beneficial effects of antihypertensive therapy on cardiovascular morbidity and mortality, could not answer the question whether antihypertensive therapy influences the development of atherosclerosis. Trials using measurements of plaque growth as endpoints are necessary.
METHODS: The traditional approach of using quantitative coronary arteriography for assessing the course of coronary artery disease during treatment cannot obviously be used in uncomplicated hypertensive patients. B-mode quantitative ultrasound assessment of intima-media thickness (IMT) of the carotid artery wall is now being used in several trials comparing different antihypertensive drugs. The major advantage of this approach is that it is non-invasive; it has also been demonstrated that IMT measurements are well reproducible. Limits of normality, definition of plaques and rate of growth of IMT in hypertension are still uncertain, however. Additionally, ultrasonographic techniques do not clearly distinguish between media and intima, and it is difficult to decide how many of the carotid wall lesions observed in hypertension are due to media hypertrophy related to hypertension or to intima changes related to atherosclerosis, although it is likely that the largest lesions have an atherosclerotic component.
PREVALENCE AND CLINICAL SIGNIFICANCE OF IMT: Baseline data from two recent trials, the VHAS and the ELSA, indicate that carotid wall lesions are highly prevalent in hypertension, but the prevalence level obviously depends on the criteria used for defining these lesions. It is known that elevated systolic blood pressure is an important risk factor for carotid lesions, and epidemiological surveys have shown that increased carotid IMT is more frequently associated with history and signs of coronary artery or cerebrovascular disease. Some evidence from a prospective study is also available, and the VHAS findings support this conclusion. Trials of antihypertensive therapy using IMT as endpoint are, therefore, likely to provide clinically useful information.
A Zanchetti
Related Documents :
20524096 - Comparing angiotensin ii receptor blockers on benefits beyond blood pressure.
16945056 - Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressu...
17948036 - Variation of blood pressure during topical phacoemulsification.
12379166 - Are all antihypertensive drug classes equal in reducing left ventricular hypertrophy?
11847186 - Blood pressure and nacl-sensitive hypertension are influenced by angiotensin-converting...
24581676 - Low dietary sodium in diabetes nephropathy.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Blood pressure. Supplement     Volume:  2     ISSN:  0803-8023     ISO Abbreviation:  Blood Press Suppl     Publication Date:  1997  
Date Detail:
Created Date:  1998-04-20     Completed Date:  1998-04-20     Revised Date:  2013-07-15    
Medline Journal Info:
Nlm Unique ID:  9300787     Medline TA:  Blood Press Suppl     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  97-102     Citation Subset:  IM    
Istituto di Clinica Medica, University of Milan, Ospedale Maggiore, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / therapeutic use
Arteriosclerosis / complications*,  physiopathology,  ultrasonography
Carotid Arteries / pathology,  ultrasonography
Hypertension / complications*,  drug therapy
Ultrasonography, Doppler, Pulsed
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical value of blood pressure variability.
Next Document:  Insulin resistance as an intermediary endpoint.